Abstract

India's home-grown biotech companies must strike a balance between domestic and international markets.

1. Sarah E. Frew, Rahim Rezaie, Monali Ray, Abdallah S. Daar and Peter A. Singer are at the McLaughlin-Rotman Centre for Global Health, Program on Life Sciences, Ethics and Policy, University Health Network/McLaughlin Centre for Molecular Medicine at University of Toronto, MaRS Centre, South Tower, Suite 406, 101 College Street, Toronto, Ontario, M5G 1L7, Canada. e-mail: peter.singer@utoronto.ca
2. Stephen M. Sammut is at Wharton Health Care Systems, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6218, USA and Burrill & Company, San Francisco, California, 94111 USA.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NPG Journals

by Subject Area

• Chemistry

  • Chemistry
  • Drug discovery
  • Biotechnology
  • Materials
  • Methods & Protocols

• Clinical Practice & Research

  • Cancer
  • Cardiovascular medicine
  • Dentistry
  • Endocrinology
  • Gastroenterology & Hepatology
  • Methods & Protocols
  • Pathology & Pathobiology
  • Urology

• Earth & Environment

  • Earth sciences
  • Evolution & Ecology

• Life sciences

  • Biotechnology
  • Cancer
  • Development
  • Drug discovery
  • Evolution & Ecology
  • Genetics
  • Immunology
  • Medical research
  • Methods & Protocols
  • Microbiology
  • Molecular cell biology
  • Neuroscience
  • Pharmacology
  • Systems biology

• Physical sciences

  • Physics
  • Materials

by A - Z Index